The first drug-eluting stents (DESs ... Patients with both types of stent were excluded. There were significant differences in baseline characteristics between the two groups; congestive heart ...

Since their introduction, drug-eluting stents (DES) have revolutionized percutaneous treatment of coronary artery disease with rates of in-stent restenosis of between 2 and 10% and significant ...

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.